CDC Panel Recommends U.S. Resume Use of J&J Covid Vaccine, Saying Benefits Outweigh Risks

A CDC advisory panel on Friday recommended the U.S. resume using the Johnson and Johnson Covid-19 vaccine.

NBC Connecticut